- Scrip Originals
Brought to you by
Morphic nets $96.3mm via IPO
02 Jul 2019
Morphic Therapeutic Inc. netted $96.26mm through its initial public offering on the Nasdaq of 6.9mm common shares (including full exercise of the overallotment) at $15 each. It had planned to sell 5mm shares between $14 and $16.
Already a Biomedtracker subscriber? You have access to the full deal record through your subscription
Want to become a subscriber? Subscribers get more deal details, updates, deal financials and deal products.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com